Ignite Creation Date:
2025-12-25 @ 12:44 AM
Ignite Modification Date:
2025-12-30 @ 1:36 PM
Study NCT ID:
NCT00047567
Status:
TERMINATED
Last Update Posted:
2015-12-14
First Post:
2002-10-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Open-label Adjunctive Zonisamide for Bipolar Disorder
Sponsor:
Elan Pharmaceuticals
Organization:
Study Overview
Official Title:
None
Status:
TERMINATED
Status Verified Date:
2015-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To study the safety and efficacy of zonisamide as adjunctive therapy for children and adolescents with bipolar I or II disorder.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: